Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Samonis

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2011
Infections in traumatic brain injury patientsI S Kourbeti, A F Vakis, J A Papadakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancerC Kouroussis, N Androulakis, S Kakolyris, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2013
Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research GroupN Kentepozidis, A Kotsakis, A Soultati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trialJ Souglakos, D Mavroudis, S Kakolyris, et al.
Oncology Reports|December 7, 2002
A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neckH Varveris, M Mazonakis, M Vlachaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsD Mavroudis, P Pappas, C Kouroussis, et al.
British Journal of Cancer|September 22, 2005
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II studyV Georgoulias, A Agelidou, K Syrigos, et al.
Infection Control and Hospital Epidemiology|April 26, 2011
Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignanciesN G Almyroudis, A J Lesse, T Hahn, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II studyD Mavroudis, G Pavlakou, G Blazoyiannakis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2017
Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countriesP Ioannidis, D van Soolingen, I Mokrousov, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2011
Infections in traumatic brain injury patientsI S Kourbeti, A F Vakis, J A Papadakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancerC Kouroussis, N Androulakis, S Kakolyris, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2013
Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research GroupN Kentepozidis, A Kotsakis, A Soultati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trialJ Souglakos, D Mavroudis, S Kakolyris, et al.
Oncology Reports|December 7, 2002
A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neckH Varveris, M Mazonakis, M Vlachaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsD Mavroudis, P Pappas, C Kouroussis, et al.
British Journal of Cancer|September 22, 2005
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II studyV Georgoulias, A Agelidou, K Syrigos, et al.
Infection Control and Hospital Epidemiology|April 26, 2011
Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignanciesN G Almyroudis, A J Lesse, T Hahn, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II studyD Mavroudis, G Pavlakou, G Blazoyiannakis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2017
Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countriesP Ioannidis, D van Soolingen, I Mokrousov, et al.
Pageof 14